Visiongain has launched a new report on Global Direct-to-Patient Market Forecast 2021-2031: Market Breakdown by Type (Direct-to-Patient Marketing, Direct-to-Patient Health Services, Direct-to-Patient Clinical Trials, Direct-to-Patient Logistics) Market Breakdown by Direct-to-Patient Marketing (DTC Prescribed Drug Advertising, Disease Awareness Campaigns, Brand Promotion, Healthcare Services Promotion, Laboratory Testing Promotion, Other Direct-to-Patient Marketing) Market Breakdown by Direct-to-Patient Health Services (Tele Consultation, Drug Prescription, Medical Call Centres, Tele sampling, Online Services) Market Breakdown by Clinical Trials (Tele Health Screening, Investigational Medicinal Product (IMP), Patient Support Systems, Other Clinical Trial Services) Market Breakdown by Logistics (Prescribed Medicine Delivery, Pre-Clinical Supplies, Clinical Trial Supplies, Home Trial Support, Test Samples Collection, Rest All CSO Services) Market Breakdown by Therapeutics (Cardiovascular Disease, Respiratory Diseases, Oncology, Infectious Diseases, Dermatology, Other Therapeutics) Market Breakdown by Model (Investigator Site Pharmacy, Central Pharmacy, Depot Distribution to Local Pharmacy, Direct from Patient, Other DtP Models) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped, W-shaped, U-shaped, L-shaped) Profiles of Leading Companies, Region and Country.
Global Direct-to-Patient Market Outlook
Visiongain’s Lead expert says: ‘The global direct-to-patient market was valued at US$38,651 million in 2020 and is projected to reach a market value of US$67,897 million by 2031. The Global market is expected to grow at a CAGR of 5.8% during the forecast period 2021-2031’.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/dtp-market-2021/#download_sampe_div
Key Questions Answered by this Report:
What is the current size of the overall global direct-to-patient market? How much will this market be worth from 2021 to 2031?
What are the main drivers and restraints that will shape the overall Direct-to-Patient market over the next ten years?
What are the main segments within the overall Direct-to-Patient market?
How much will each of these segments be worth for the period 2021 to 2031?
How will the composition of the market change during that time, and why?
What factors will affect that industry and market over the next ten years?
What are the largest national markets for the world direct-to-patient?
What is their status and how will they develop over the next ten years?
What are their revenue potentials to 2031?
How will political and regulatory forces influence regional markets?
How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
Who are the leading companies and what are their activities, results, developments, and prospects?
What are the leading Direct-to-Patient? What are their revenues and latest developments?
What are some of the most prominent Direct-to-Patient currently in development?
What are the main trends that will affect the world direct-to-patient market between 2021 and 2031?
What are the main strengths, weaknesses, opportunities, and threats for the market?
What are the social, technological, economic, and political influences that will shape that industry over the next ten years?
How will the global Direct-to-Patient market evolve over the forecasted period, 2021 to 2031?
What will be the main commercial drivers for the market from 2021 to 2031?
How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving the highest revenues and fastest growth?
How will that industry evolve between 2021 and 2031, especially in R&D?
DTP would be the First Point of Contact to Support Patients in near Future
This pioneering role ensures a very high level of market coverage because it supports essentially all types of studies (drug studies, research into medical devices, non-interventional drug studies, registry trials, epidemiology, academic or industry-sponsored studies). Although no funding for basic research is currently planned, a DTP can support it if it is necessary. In the meantime, the emphasis is on developing a DTP model that is used as a role model for establishing additional DTP in other potential areas.
DTP Helps Clinical Trials to Find and Retain Patients
Recruiting and enrolling participants is generally the most challenging phase of a clinical study, with approximately 80% of studies failing to fulfil their initial objectives. Patients and their families benefit from the direct-to-patient clinical trial since it lowers site visits and overall strain. A clinical trial that reduces the burden on a patient's lifestyle has the potential to enhance recruitment by 60% or more, with over 95% of patients completing the study on average.
Get Detailed TOC @ https://www.visiongain.com/report/dtp-market-2021/#download_sampe_div
Discover sales predictions for the global direct-to-patient market and submarkets.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services. DTP companies supply systems for home care, medicines, products for personal hygiene, collection of test samples and reporting. Along with revenue prediction for the overall world market, there is market value, with forecasts for 4 types, 6 Marketing, 5 Health Services, 6 Clinical Trials, 6 Logistics, each forecasted at a global, regional, and country-level, along with COVID-19 impact recovery pattern analysis for all segments.
Who are the leading players analyzed in the market?
American Well Corporation
Teladoc Health, Inc.
Doctor on Demand
Specialists On Call Inc.
Doctor Anywhere Pte. Ltd.
Practo Technologies Private Limited
Hims & Hers Health, Inc.
AGNITY Global Inc.
AMD Global Telemedicine, Inc.
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email email@example.com
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the Direct-to-Patient Health Market and leading companies. Here you will find data, trends and predictions. Please order our report now.
Find more Visiongain research reports on Healthcare Sector click on the following links:
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: firstname.lastname@example.org
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.
Tel: + 44 207 549 9987
USA Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
Follow Us: LinkedIn | Twitter
SOURCE Visiongain Limited.